Papers › SMART-MC: Characterizing the Dynamics of Multiple Sclerosis Therapy Transitions Using...
SMART-MC: Characterizing the Dynamics of Multiple Sclerosis Therapy Transitions Using a Covariate-Based Markov Model
Beomchang Kim, Zongqi Xia, Priyam Das
The archive published only this paper's code-link row. Authors, date and abstract are from arXiv's metadata (CC0), read from the Kaggle arXiv metadata snapshot of 2026-09-12 where its title matched the archive's; the title is the archive's.
Treatment switching is a common occurrence in the management of Multiple Sclerosis (MS), where patients transition across various disease-modifying therapies (DMTs) due to heterogeneous treatment responses, differences in disease progression, patient characteristics, and therapy-associated adverse effects. To investigate how patient-level covariates influence the likelihood of treatment transitions among DMTs, we adopt a Markovian framework, Sparse Matrix Estimation with Covariate-Based Transitions in Markov Chain Modeling (SMART-MC), in which the transition probabilities are modeled as functions of these covariates. Modeling real-world treatment transitions under this framework presents several challenges, including ensuring parameter identifiability and handling sparse transitions without overfitting. To address identifiability, we constrain each transition-specific covariate coefficient vectors to have a fixed L2 norm. Furthermore, our method automatically estimates transition probabilities for sparsely observed transitions as constants and enforces zero transition probabilities for transitions that are empirically unobserved. This approach mitigates the need for additional model complexity to handle sparsity while maintaining interpretability and efficiency. To optimize the multi-modal likelihood function, we develop a scalable, parallelized global optimization routine, which is validated through benchmark comparisons and supported by key theoretical properties. Our analysis uncovers meaningful patterns in DMT transitions, revealing variations across MS patient subgroups defined by age, race, and other clinical factors.
Code
Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.
Code Syntology ran Syntology
Not run by Syntology. Nothing on this page verifies that the listed code works.
Results from the paper archive 2025-07-28
No leaderboard rows for this paper in the archive.
Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections